BI 1839100, Placebo matching in size, weight, colour and shape to tablets of BI 1839100
1490-0004
Phase 2 small_molecule active
Quick answer
BI 1839100, Placebo matching in size, weight, colour and shape to tablets of BI 1839100 for Progressive pulmonary fibrosis (PPF), Idiopathic pulmonary fibrosis (IPF) is a Phase 2 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Progressive pulmonary fibrosis (PPF), Idiopathic pulmonary fibrosis (IPF)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active